Pfizer captures NY medical institutions in new innovation centre: London next?
This article was originally published in Scrip
As Pfizer announced that the second and largest of its Centres for Therapeutic Innovation (CTI) will be in New York, Tony Coyle, head of Pfizer's Global CTIs, told Scrip that a further centre in the network would be announced in the next few weeks, with London as a prime candidate.
You may also be interested in...
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.
In a flat month, the market value of big pharma changed little overall. But the balance of power in immuno-oncology did shift significantly.